Using toluidine blue as an adjunct to oral visual cancer screening among high-risk individuals may lead to increased detection of oral submucous fibrosis
- PMID: 22078834
- DOI: 10.1016/j.jebdp.2011.09.003
Using toluidine blue as an adjunct to oral visual cancer screening among high-risk individuals may lead to increased detection of oral submucous fibrosis
Abstract
Article title and bibliographic information: A community-based RCT for oral cancer screening with toluidine blue. Su WW, Yen AM, Chiu SY, Chen TH. J Dent Res 2010;89(9):933-7.
Reviewer: Mark D. Macek, DDS, DrPH PURPOSE/QUESTION: Does using toluidine blue as an adjunctive tool for oral visual cancer screening lead to higher detection rates of oral premalignant lesions among high-risk populations?
Source of funding: Information not available
Type of study/design: Randomized controlled trial
Level of evidence: Level 2: Limited-quality, patient-oriented evidence
Strength of recommendation grade: Not applicable.
Copyright © 2011 Elsevier Inc. All rights reserved.
Comment on
-
A community-based RCT for oral cancer screening with toluidine blue.J Dent Res. 2010 Sep;89(9):933-7. doi: 10.1177/0022034510373763. Epub 2010 Jun 4. J Dent Res. 2010. PMID: 20525960 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
